Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Maria Shkrob

Maria Shkrob

Sr Bioinformatics Scientist

Connect with Maria Shkrob on LinkedIn

About the author: Maria has 7 years of experience in the bioinformatics industry, working on the solutions for text and data mining. At Elsevier Maria works as a Project Manager for Elsevier Professional Services applying the rich R&D Solutions portfolio to address customers’ needs. Maria holds a PhD in Molecular Biology.

Posts by Maria Shkrob

When insights from pharma help fight fungus

Posted on March 24th, 2020 in Pharma R&D

Fungicide resistance is a growing problem, as evidenced by publication trends. Publications on this issue are particularly high across the world’s major economies, and many focus specifically on the fungus Botrytis.


Building models for rare diseases

Posted on June 2nd, 2016 in Pharma R&D

We continue the series of stories about the exciting collaboration between the UK charity Findacure and Elsevier. Findacure’s mission is to empower rare disease patient groups, facilitate treatment (more…)

Using Text Mining to Find Treatments for Rare Diseases

Posted on May 5th, 2016 in Pharma R&D

When you compare PubMed search results for rare diseases, such as “congenital hyperinsulinism” (767), schwannomatosis (250) or “Mabry syndrome” (34), to that of “diabetes” (542,987), “heart attack” (217,694) or “obesity” (237,307), the disparity in attention becomes much more obvious. (more…)

Drug Repurposing for Rare Diseases

Posted on April 27th, 2016 in Pharma R&D

Elsevier’s partnership with a UK charity Findacure started last year with a very touching and inspirational talk from Dr. Nick Sireau, a parent of two children diagnosed with alkaptonuria. Very soon after his first child was born, Nick found himself (more…)